Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Johnson & Johnson, et al., Petitioners v. Gail L. Ingham, et al.
Case Number:
20-1223
Court:
Nature of Suit:
Firms
- Dechert LLP
- Foley Hoag
- Gallivan White
- Goldstein & Russell
- Hogan Lovells
- Hollingsworth LLP
- Lanier Law Firm
- Mayer Brown
- Reed Smith
- Taft Stettinius
Companies
Sectors & Industries:
-
June 01, 2021
High Court Won't Hear J&J Challenge To $2.1B Talc Verdict
The U.S. Supreme Court on Tuesday refused to take on Johnson & Johnson's challenge to a $2.1 billion verdict awarded in Missouri to nearly two dozen women who blamed the purported asbestos in its talcum powder for their ovarian cancer, brushing aside the company's argument that too many claims were combined for a single trial.
-
April 06, 2021
Business Groups Ask High Court To Review $2.1B J&J Verdict
The U.S. Chamber of Commerce and other business organizations urged the U.S. Supreme Court on Monday to review a Missouri jury's $2.1 billion verdict against Johnson & Johnson after finding its talcum powder products gave 22 women ovarian cancer, saying the consolidation of such cases hampers defendants' due process rights.
-
March 23, 2021
J&J Seeks High Court Holy Grail: A Cap On Punitive Damages
If the U.S. Supreme Court reviews Johnson & Johnson's $2.1 billion loss to cancer patients who blamed the company's talcum powder for their illness, the case could be a chance to place new constraints on juries' power to award punitive damages — a change high on the corporate defense bar's wish list for decades.